New Treatment Targets and Approaches for Hepatitis B Virus

Author(s): Murat Afyon*, Cumhur Artuk.

Journal Name: Anti-Infective Agents
Anti-Infective Agents in Medicinal Chemistry

Volume 15 , Issue 1 , 2017

Become EABM
Become Reviewer

Graphical Abstract:


Introduction: With the development of the direct acting antivirals aganist hepatitis C virus (HCV), the treatment of HCV has showed significiant progress. However, hepatitis B virus (HBV) therapy is still a topic of discussion.

Objectives: Because of that approved agents for HBV have some disadvantages including indefinite therapy, drug resistance, adverse effects and persistence of covalently closed circular deoxyribonucleic acid (cccDNA), there is a need for new treatment targets and approaches for HBV. And, there are several trials about this subject. New treatment targets for HBV consist revers transcription, immunoregulation, cccDNA formation and regulation, maturation and secretion of infectious virions and subviral particules, viral receptor, entry and cytosolic transport, nucleocapsid assembly. Therapeutic vaccination and traditional Chinese medicine are the other options for novel agents for HBV treatment. We summarised new treatment targets and approaches for HBV.

Conclusion: It is a certain fact that large-scale studies about all these molecules and approaches are required, in order to highlight the efficiency, drug interaction, safety and appropriate dose.

Keywords: Hepatitis B virus, treatment, nucleos(t)id analogues, cccDNA, immunoregulators, viral entry, traditional Chinese medicine.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Page: [4 - 8]
Pages: 5
DOI: 10.2174/2211352514666161025113118
Price: $25

Article Metrics

PDF: 39
PRC: 1